Northern Trust’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-515,955
| Closed | -$8.12M | – | 4497 |
|
|
2024
Q1 | $8.12M | Sell |
515,955
-9,548
| -2% | -$147K | ﹤0.01% | 2177 |
|
|
2023
Q4 | $8.48M | Buy |
525,503
+5,007
| +1% | +$63.9K | ﹤0.01% | 2174 |
|
|
2023
Q3 | $6.62M | Buy |
520,496
+2,731
| +0.5% | +$37.7K | ﹤0.01% | 2268 |
|
|
2023
Q2 | $7.29M | Buy |
517,765
+12,094
| +2% | +$173K | ﹤0.01% | 2269 |
|
|
2023
Q1 | $7.81M | Buy |
505,671
+64,805
| +15% | +$1.08M | ﹤0.01% | 2186 |
|
|
2022
Q4 | $7.23M | Buy |
440,866
+8,206
| +2% | +$133K | ﹤0.01% | 2231 |
|
|
2022
Q3 | $8M | Sell |
432,660
-816
| -0.2% | -$12.8K | ﹤0.01% | 2152 |
|
|
2022
Q2 | $5.7M | Buy |
433,476
+32,449
| +8% | +$358K | ﹤0.01% | 2420 |
|
|
2022
Q1 | $3.72M | Sell |
401,027
-9,673
| -2% | -$82.3K | ﹤0.01% | 2756 |
|
|
2021
Q4 | $4.01M | Buy |
410,700
+9,740
| +2% | +$183K | ﹤0.01% | 2822 |
|
|
2021
Q3 | $13.6M | Sell |
400,960
-23,379
| -6% | -$746K | ﹤0.01% | 2060 |
|
|
2021
Q2 | $15.5M | Sell |
424,339
-14,852
| -3% | -$575K | ﹤0.01% | 2066 |
|
|
2021
Q1 | $19.7M | Sell |
439,191
-17,008
| -4% | -$792K | ﹤0.01% | 1835 |
|
|
2020
Q4 | $26M | Sell |
456,199
-1,630
| -0.4% | -$96.6K | 0.01% | 1613 |
|
|
2020
Q3 | $23.5M | Buy |
457,829
+9,559
| +2% | +$468K | 0.01% | 1501 |
|
|
2020
Q2 | $26.8M | Buy |
448,270
+171,828
| +62% | +$9.19M | 0.01% | 1383 |
|
|
2020
Q1 | $11.4M | Buy |
276,442
+16,962
| +7% | +$942K | ﹤0.01% | 1793 |
|
|
2019
Q4 | $16.1M | Buy |
259,480
+12,832
| +5% | +$610K | ﹤0.01% | 1875 |
|
|
2019
Q3 | $8.37M | Buy |
246,648
+123,979
| +101% | +$3.67M | ﹤0.01% | 2257 |
|
|
2019
Q2 | $2.77M | Sell |
122,669
-12,020
| -9% | -$281K | ﹤0.01% | 2876 |
|
|
2019
Q1 | $3.13M | Sell |
134,689
-4,305
| -3% | -$113K | ﹤0.01% | 2819 |
|
|
2018
Q4 | $2.92M | Sell |
138,994
-1,175
| -0.8% | -$28.9K | ﹤0.01% | 2836 |
|
|
2018
Q3 | $5.43M | Buy |
140,169
+25,343
| +22% | +$936K | ﹤0.01% | 2637 |
|
|
2018
Q2 | $4.52M | Buy |
114,826
+30,094
| +36% | +$886K | ﹤0.01% | 2730 |
|
|
2018
Q1 | $1.7M | Buy |
84,732
+9,640
| +13% | +$244K | ﹤0.01% | 3187 |
|
|
2017
Q4 | $1.7M | Buy |
+75,092
| New | +$1.47M | ﹤0.01% | 3221 |
|
Other funds holding DCPH
Northern Trust's DCPH Position: Q2 2024 in Review
Northern Trust sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 515,955 shares — an estimated $8.12M sold.
Northern Trust first reported a position in DCPH in Q4 2017 and held it in 26 quarters. The position peaked at $26.8M in Q2 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Northern Trust reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Northern Trust sold 515,955 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $8.12M.
- Northern Trust first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 26 quarters.
- Northern Trust's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $26.8M in Q2 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Northern Trust's 13F filing for Q2 2024, filed 14 Aug 2024.